Artificial cationic oligosaccharides for heteroduplex oligonucleotide-type drugs
Crossref DOI link: https://doi.org/10.1038/s41598-018-22161-8
Published Online: 2018-03-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hara, Rintaro Iwata
Hisada, Yuki
Maeda, Yusuke
Yokota, Takanori
Wada, Takeshi
Text and Data Mining valid from 2018-03-12
Version of Record valid from 2018-03-12
Article History
Received: 25 September 2017
Accepted: 19 February 2018
First Online: 12 March 2018
Competing Interests
: The authors declare no competing interests.